ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1263

Carotid Arterial Wall Inflammation Is Associated with a Specific Profile of Inflammatory Biomarkers and Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Patients

Caroline Grönwall1, Gregg J. Silverman1, Zahi Fayad2, Venkatesh Mani2, Victoria Furer3, Michael Farkouh2, Manish Jain1, Cheongeun Oh4, John Todd5, Mukundan Attur6, Steven B. Abramson7 and Jeffrey D. Greenberg8, 1Rheumatology, NYU School of Medicine, New York, NY, 2Mount Sinai Hospital, New York, NY, 3Rheumatology, Tel-Aviv Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel, 4Biostatistics, NYU School of Medicine, New York, NY, 5Singulex, Alameda, California, Alameda, CA, 6Division of Rheumatology, Department of Medicine, NYU Hospital for Joint Diseases, New York, NY, 7Dept of Rheumatology/Medicine, NYU Langone Medical Center, New York, NY, 8New York Hospital for Joint Disease, New York, NY

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Biomarkers, Cardiovascular disease and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects II: Clinical Features & Comorbidity/Cardiovascular Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Patients with RA are at increased risk of cardiovascular (CV) comorbidity and premature mortality. While generally attributed to accelerated atherosclerosis, the pathogenesis remains poorly understood.

Methods:

To investigate cardiovascular disease in RA, we measured carotid and aortic wall inflammation by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) uptake and vessel wall morphology by MRI in a cross-sectional study (N=30 pts). We calculated Mean and Maximum Target to Background Ratio (TBR) values as measures of arterial wall inflammation.  Left and right carotid TBRs were combined as mean carotid values.  Inflammation-related serum analytes were measured by commercial ELISA (sRAGE), and with a custom plasma panel for inflammation-related proteins, including cytokines, matrix metalloproteinases (MMPs), MMP inhibitors and trophic factors (Singulex Inc.). High-sensitivity cardiac troponin I (cTn-I) was also measured (Singulex Inc) as a marker of myocardial injury.  IgG antibodies to citrullinated (cit) peptides from fibrinogen (Fib), histone 2A, filaggrin, a-enolase, and vimentin were determined by quantitative ELISA, and CCP3 using a commercial clinical assay (Inova Diagnostics Inc.). Protein peptide-specific ACPA assays were validated with a panel of sera from RA, OA and healthy individuals.

Results:

The mean age was 51.2 years, mean DAS28 score 6.7 (range 2.2-6.7), 80% female and 11(36%) were on biologic DMARDs.  Carotid Max TBR was associated with higher levels of cTn-I (r=0.566, p=0.01), indicating an association of carotid wall inflammation with subclinical myocardial injury.  Of the 15 inflammatory biomarkers assessed, carotid max TBR values was associated with elevations of  sRAGE, VEGF, MMP8, proMMP9 and IL-1b. (Table 1). Similar results were obtained for carotid mean TBR.  Strikingly, there was a strong correlation between carotid max TBR and cit-Fib IgG (R=0.72, p=0.0005). Furthermore, patients with a positive Cit-Fib IgG test (n=10) had higher levels of carotid wall inflammation [max TBR (p-0.04), mean TBR (p=0.03)] than Cit-Fib IgG negative pts. No correlation was found between carotid TBR values and levels of IgG CCP3.  Neither IgG antibodies nor any of the inflammatory biomarkers correlated with aorta TBR measures.  By MRI, we found significant correlations between wall thickness and ACPA IgGs specific for citrullinated fibrinogen, filaggrin, and enolase, as well as plasma hsCRP and pMMP9.levels (p<0.05).    

Conclusion:

These FDG-PET studies indicate that a subset of RA patients exhibit inflammatory carotid artery disease.   Carotid inflammation was associated with elevations of a distinct profile of innate inflammatory markers and citrullinated self-protein-specific IgG.  These data may provide insights into the immunopathogenesis of RA-associated CV disease.

Table: Associations of carotid wall inflammation (max TBR) and biomarkers

Biomarker

Spearman (r)

P-value

cTn-I

0.57

0.01

sRAGE

0.43

0.07

VEGF

0.59

0.008

MMP8

0.62

0.004

pMMP9

0.58

0.008

IL1β

0.48

0.03

IgG anti-Cit-Fib

0.72

0.0005


Disclosure:

C. Grönwall,
None;

G. J. Silverman,
None;

Z. Fayad,
None;

V. Mani,
None;

V. Furer,
None;

M. Farkouh,
None;

M. Jain,
None;

C. Oh,
None;

J. Todd,

Singulex,

3;

M. Attur,
None;

S. B. Abramson,
None;

J. D. Greenberg,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/carotid-arterial-wall-inflammation-is-associated-with-a-specific-profile-of-inflammatory-biomarkers-and-anti-citrullinated-protein-antibodies-in-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology